BNN Bloomberg

BNN Bloomberg’s Market Call: Robert Lauzon – March 25, 2024 (Full Interview)

Middlefield CIO, Rob Lauzon, joins BNN Bloomberg's Market Call to share his current market outlook, top stock picks and to answer viewer questions.

  • All Solutions
  • BNN Bloomberg’s Market Call: Robert Lauzon – March 25, 2024 (Full Interview)
M-Asset

Market Outlook:

The index of leading economic indicators increased in February for the first time since early 2022, while the index of coincident economic indicators is up 1.9 per cent year-over-year, confirming real gross domestic product (GDP) growth and our view that the economy is experiencing a “soft landing.”

Front-page news highlights momentum and crowding in a handful of stocks. However, under the surface, lots of new leadership is emerging in healthcare, financials, energy, select utilities and REITs (real estate investment trusts). Also worth highlighting is that we are detecting a broadening out in the technology sector; IBM is a notable example. These trends are resulting in a cyclical and structural rebound in mergers and acquisitions (M&A) and we believe a multi-year cycle is upon us. Global M&A announcements are tracking more than 31 per cent over this time last year. Moreover, recent data also suggests the window is opening for both equity financings and IPOs (initial public offerings). With interest rates set to recede in the near term, we expect both institutional and retail money to flow out of short-term cash instruments and into equity income sectors and monthly equity income funds and ETFs.

Top Picks:

Intellia Therapeutics (NTLA TSX)

After sluggish performance in biotech for over the past two years, funds are flowing back into the sector. Gene-editing technologies are extremely promising, offering highly targeted and potentially curative treatments for a wide range of diseases. Intellia utilizes CRISPR technology to target specific genetic mutations with high precision with the goal of treating a variety of human diseases in the future. The company has more than US$1 billion of cash on balance sheet, which is enough to cover two years of operating expenses.

Dream Residential REIT (DRR.UN TSX)

The REIT owns garden-style complexes, which target middle-income households as renters. Demographics are favourable in their Sunbelt and Midwest target markets, such as Cincinnati, where they are repositioning units. We feel the REIT is mispriced trading above a 30 per cent discount to NAV, pays a healthy yield, which is backed by a 65 per cent payout ratio.

Topaz Energy (TPZ TSX)

Topaz gives investors a unique way to invest in the Canadian energy market. It has royalties on both oil and gas production as well as infrastructure. It collects royalties from some of the most exciting plays in the basin and from some of the highest-quality producers. We feel there is deep value associated with their assets, which should be realized for patient investors.

Disclosure Personal Family Portfolio/Fund
NTLA TSX N N Y
DRR.UN TSX N N Y
TPZ TSX N N Y

Past Picks: September 1, 2023

Chartwell Retirement Residences (CSH.UN TSX)

  • Then: $10.54
  • Now: $12.28
  • Return: 16%
  • Total Return: 20%

Medtronic (MDT TSX)

  • Then: US$82.13
  • Now: US$82.97
  • Return: 1%
  • Total Return: 3%

Enbridge (ENB TSX)

  • Then: $48.28
  • Now: $48.38
  • Return: 0.2%
  • Total Return: 4%

Total Return Average: 9%

Disclosure Personal Family Portfolio/Fund
CSH.UN TSX N N Y
MDT TSX N N Y
ENB TSX N N Y

 

 

 

 

Disclaimer

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. You will usually pay brokerage fees to your dealer if you purchase or sell units/shares of investment funds on the Toronto Stock Exchange or other alternative Canadian trading system (an “Exchange”). If the units/shares are purchased or sold on an Exchange, investors may pay more than the current net asset value when buying and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning units or shares of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents. Mutual funds and investment funds are not guaranteed, their values change frequently and past performance may not be repeated. Certain statements in this disclosure are forward-looking. Forward-looking statements (“FLS”) are statements that are predictive in nature, depend upon or refer to future events or conditions, or that include words such as “may”, “will”, “should”, “could”, “expect”, “anticipate”, “intend”, “plan”, “believe”, or “estimate”, or other similar expressions. Statements that look forward in time or include anything other than historical information are subject to risks and uncertainties, and actual results, actions or events could differ materially from those set forth in the FLS. FLS are not guarantees of future performance and are by their nature based on numerous assumptions. Although the FLS contained herein are based upon what Middlefield Funds and the portfolio manager believe to be reasonable assumptions, neither Middlefield Funds nor the portfolio manager can assure that actual results will be consistent with these FLS. The reader is cautioned to consider the FLS carefully and not to place undue reliance on FLS. Unless required by applicable law, it is not undertaken, and specifically disclaimed that there is any intention or obligation to update or revise FLS, whether as a result of new information, future events or otherwise.

This material has been prepared for informational purposes only without regard to any particular user’s investment objectives or financial situation. This communication constitutes neither a recommendation to enter into a particular transaction nor a representation that any product described herein is suitable or appropriate for you. Investment decisions should be made with guidance from a qualified professional. The opinions contained in this report are solely those of Middlefield Limited (“ML”) and are subject to change without notice. ML makes every effort to ensure that the information has been derived from sources believed to reliable, but we cannot represent that they are complete or accurate. However, ML assumes no responsibility for any losses or damages, whether direct or indirect which arise from the use of this information. ML is under no obligation to update the information contained herein. This document is not to be construed as a solicitation, recommendation or offer to buy or sell any security, financial product or instrument.

  • All Solutions
  • BNN Bloomberg’s Market Call: Robert Lauzon – March 25, 2024 (Full Interview)
Close
Subscribe to Our Insights!
Flyout Form
Close
Subscribe for MCT Updates
Flyout Form UK
Close
Register Today
Due Diligence Event
Close
Register Today
Due Diligence Event